Max Robotics — Global Service Robot Directory + US Certification

About

P. Wiklund is a pioneering figure in urologic oncology, best known for advancing robot-assisted radical cystectomy (RARC) as a standard treatment for bladder cancer. As a founding member of the International Robotic Cystectomy Consortium (IRCC), Wiklund led landmark studies that established the safety and feasibility of minimally invasive approaches for complex pelvic surgeries. Their most-cited work, "PE67: Early oncologic failure after robot-assisted radical cystectomy: Results from the international robotic cystectomy consortium" (2014), provided critical early evidence on recurrence patterns and surgical outcomes, helping to refine patient selection and operative techniques. Though citation counts for this specific paper are modest, Wiklund’s broader contributions—including long-term oncologic follow-up studies—have shaped global practice, with the IRCC’s cumulative work cited hundreds of times. A notable achievement includes authoring a reply (2019) in the *Journal of Urology* that defended ten-year oncologic outcomes from the IRCC, reinforcing the durability of RARC results. Wiklund’s research has been instrumental in demonstrating that robotic surgery can achieve oncologic efficacy comparable to open approaches while reducing morbidity, making them a key voice in the evolution of evidence-based, minimally invasive urologic oncology.